The market has been high on Selecta Biosciences Inc (SELB) stock recently. SELB gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.
As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.
Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish.
InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion.
For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.
What's Happening With SELB Stock Today?
Selecta Biosciences Inc (SELB) stock has gained 5.19% while the S&P 500 has fallen -1.37% as of 1:07 PM on Wednesday, Jan 27. SELB is higher by $0.22 from the previous closing price of $4.26 on volume of 1,964,591 shares. Over the past year the S&P 500 is higher by 17.06% while SELB is higher by 53.95%. SELB lost -$0.83 per share in the over the last 12 months.
To screen for more stocks like Selecta Biosciences Inc click here.
More About Selecta Biosciences Inc
Selecta Biosciences Inc is a clinical-stage biopharmaceutical company. The company is engaged in using synthetic vaccine particle or SVP technology to discover and develop targeted therapies to modulate the immune system effectively and safely treat rare and serious diseases. It provides SVP for immune tolerance and stimulation. The company products in Phase 1 and Phase 2 include SEL-403 for Pancreatic Cancer and Mesothelioma, SEL-212 for Chronic Severe Gout, SEL-302 for Methylmalonic Acidemia (MMA) and SEL-313 for Ornithine Transcarbamylase Deficiency (OTC).
Click Here to get the full Stock Score Report on Selecta Biosciences Inc (SELB) Stock.
